Purpose The optimal dose and fractionation of stereotactic body radiation therapy (SBRT) for
locally advanced pancreatic cancer (LAPC) have not been defined. Single-fraction SBRT …

With recent advances in imaging modalities and radiation therapy, stereotactic body
radiotherapy (SBRT) has allowed for the delivery of high doses of radiation with accuracy …

Background Dose escalation of SBRT for locally advanced pancreatic cancer patients had
been reported in several studies in one or three fractions, and phase I protocol was …

Introduction The majority of pancreatic cancers present locally advanced and carry a high
mortality rate. Treatment is challenging, with mixed data suggesting use of chemotherapy …

Purpose This systematic review aims to comprehensively summarize the current prospective
evidence regarding Stereotactic Body Radiotherapy (SBRT) in various clinical contexts for …

Purpose/objective: To analyse outcome and toxicity of stereotactic body radiotherapy
(SBRT) in pancreatic cancer (PDAC). Material/methods: We systematically reviewed full …

BACKGROUND This phase 2 multi‐institutional study was designed to determine whether
gemcitabine (GEM) with fractionated stereotactic body radiotherapy (SBRT) results in …

For many patients, a pancreatic cancer diagnosis involves a dismal (< 6%) chance of
survival beyond 5 years, and little progress has been made in terms of prevention and early …

Purpose/Objectives Locally recurrent pancreatic cancer is a therapeutic challenge, and
aggressive approaches are needed to improve its clinical outcomes. Stereotactic body …

Background/introduction Early reports of stereotactic body radiation therapy (SBRT) for
pancreatic ductal adenocarcinoma (PDAC) used single fraction, but eventually shifted to …